187
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Influence of ethanol on swelling and release behaviors of Carbopol®-based tablets

, &
Pages 1089-1100 | Received 25 Jan 2012, Accepted 30 May 2012, Published online: 09 Jul 2012

References

  • FDA Alert: Alcohol—Palladone Interaction. (2005). Available at: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm129288.htm. Accessed on 14 December 2011.
  • Roberts M, Cespi M, Ford JL, Dyas AM, Downing J, Martini LG et al. Influence of ethanol on aspirin release from hypromellose matrices. Int J Pharm 2007;332:31–37.
  • Levina M, Vuong H, Rajabi-Siahboomi AR. The influence of hydro-alcoholic media on hypromellose matrix systems. Drug Dev Ind Pharm 2007;33:1125–1134.
  • Larsson M, Hjärtstam J, Berndtsson J, Stading M, Larsson A. Effect of ethanol on the water permeability of controlled release films composed of ethyl cellulose and hydroxypropyl cellulose. Eur J Pharm Biopharm 2010;76:428–432.
  • Walden M, Nicholls FA, Smith KJ, Tucker GT. The effect of ethanol on the release of opioids from oral prolonged-release preparations. Drug Dev Ind Pharm 2007;33:1101–1111.
  • Fadda HM, Mohamed MA, Basit AW. Impairment of the in vitro drug release behaviour of oral modified release preparations in the presence of alcohol. Int J Pharm 2008;360:171–176.
  • Johnson F, Wagner G, Sun S, Stauffer J. Effect of concomitant ingestion of alcohol on the in vivo pharmacokinetics of KADIAN (morphine sulfate extended-release) capsules. J Pain 2008;9:330–336.
  • Traynor MJ, Brown MB, Pannala A, Beck P, Martin GP. Influence of alcohol on the release of tramadol from 24-h controlled-release formulations during in vitro dissolution experiments. Drug Dev Ind Pharm 2008;34:885–889.
  • Roth W, Setnik B, Zietsch M, Burst A, Breitenbach J, Sellers E et al. Ethanol effects on drug release from Verapamil Meltrex, an innovative melt extruded formulation. Int J Pharm 2009;368:72–75.
  • Smith AP, Moore TW, Westenberger BJ, Doub WH. In vitro dissolution of oral modified-release tablets and capsules in ethanolic media. Int J Pharm 2010;398:93–96.
  • Singla AK, Chawla M, Singh A. Potential applications of carbomer in oral mucoadhesive controlled drug delivery system: a review. Drug Dev Ind Pharm 2000;26:913–924.
  • Kavanagh N, Corrigan OI. Swelling and erosion properties of hydroxypropylmethylcellulose (Hypromellose) matrices–influence of agitation rate and dissolution medium composition. Int J Pharm 2004;279:141–152.
  • Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv 1985;60:110–111.
  • Ritger PL, Peppas NA. A simple equation for description of solute release.II. Fickian and anomalous release from swellable devices. J Control Release 1987;5:37–42.
  • Moore J, Flanner H. Mathematical comparison of curves with an emphasis on in vitro dissolution profiles. Pharm Technol 1996;20:64–74.
  • Guidance for Industry. (1997). Dissolution Testing of Immediate Release Solid Oral Dosage Forms. Rockville, MD: FDA Center for Drug Evaluation and Research.
  • Lubrizol. Formulating controlled release tablets and capsules with Carbopol® polymers. Pharmaceutical Bulletin No. 31, 2008.
  • Siepmann J, Siepmann F. Mathematical modeling of drug delivery. Int J Pharm 2008;364:328–343.
  • Lubrizol. Lubrizol pharmaceutical polymers for controlled release tablets and capsules. Pharmaceutical Bulletin No. 30, 2008.
  • Lubrizol. Neutralizing Carbopol® and Pemulen™ polymers in aqueous and hydro-ethanolic systems. Technical Data Sheet 237, 2009.
  • Lubrizol. Formulating hydro-ethanolic gels with Carbopol® polymers. Technical Data Sheet 255, 2009.
  • Bonacucina G, Cespi M, Misici-Falzi M, Palmieri GF. Rheological, adhesive and release characterisation of semisolid Carbopol/tetraglycol systems. Int J Pharm 2006;307:129–140.
  • Bonacucina G, Martelli S, Palmieri GF. Rheological, mucoadhesive and release properties of Carbopol gels in hydrophilic cosolvents. Int J Pharm 2004;282:115–130.
  • Parojcic J, Ethuric Z, Jovanovic M, Ibric S, Jovanovic D. Influence of dissolution media composition on drug release and in-vitro/in-vivo correlation for paracetamol matrix tablets prepared with novel carbomer polymers. J Pharm Pharmacol 2004;56:735–741.
  • Xiaoqiang X, Minjie S, Feng Z, Yiqiao H. Floating matrix dosage form for phenoporlamine hydrochloride based on gas forming agent: in vitro and in vivo evaluation in healthy volunteers. Int J Pharm 2006;310:139–145.
  • Ravi PR, Kotreka UK, Saha RN. Controlled release matrix tablets of zidovudine: effect of formulation variables on the in vitro drug release kinetics. AAPS PharmSciTech 2008;9:302–313.
  • Al-Zoubi NM, AlKhatib HS, Obeidat WM. Evaluation of hydrophilic matrix tablets based on Carbopol® 971P and low-viscosity sodium alginate for pH-independent controlled drug release. Drug Dev Ind Pharm 2011;37:798–808.
  • Goodrich BF. (1995). Controlled release tablets and capsules. Bulletin no. 17, OH: Brecksville.
  • Sujja-areevath J, Munday DL, Cox PJ, Khan KA. Relationship between swelling, erosion and drug release in hydrophillic natural gum mini-matrix formulations. Eur J Pharm Sci 1998;6:207–217.
  • Sriamornsak P, Thirawong N, Weerapol Y, Nunthanid J, Sungthongjeen S. Swelling and erosion of pectin matrix tablets and their impact on drug release behavior. Eur J Pharm Biopharm 2007;67:211–219.
  • Fu XC, Wang GP, Liang WQ, Chow MS. Prediction of drug release from HPMC matrices: effect of physicochemical properties of drug and polymer concentration. J Control Release 2004;95:209–216.
  • Kiortsis S, Kachrimanis K, Broussali T, Malamataris S. Drug release from tableted wet granulations comprising cellulosic (HPMC or HPC) and hydrophobic component. Eur J Pharm Biopharm 2005;59:73–83.
  • Bustamante P, Navarro-Lupión J, Peña MA, Escalera B. Hildebrand solubility parameter to predict drug release from hydroxypropyl methylcellulose gels. Int J Pharm 2011;414:125–130.
  • Finnigan F, Hammersley R, Millar K. Effects of meal composition on blood alcohol level, psychomotor performance and subjective state after ingestion of alcohol. Appetite 1998;31:361–375.
  • Johnson RD, Horowitz M, Maddox AF, Wishart JM, Shearman DJ. Cigarette smoking and rate of gastric emptying: effect on alcohol absorption. BMJ 1991;302:20–23.
  • Maddern GJ, Horowitz M, Hetzel DJ, Jamieson GG. Altered solid and liquid gastric emptying in patients with duodenal ulcer disease. Gut 1985;26:689–693.
  • Maluenda F, Csendes A, De Aretxabala X, Poniachik J, Salvo K, Delgado I et al. Alcohol absorption modification after a laparoscopic sleeve gastrectomy due to obesity. Obes Surg 2010;20:744–748.
  • Amir I, Anwar N, Baraona E, Lieber CS. Ranitidine increases the bioavailability of imbibed alcohol by accelerating gastric emptying. Life Sci 1996;58:511–518.
  • Kechagias S, Jönsson KA, Norlander B, Carlsson B, Jones AW. Low-dose aspirin decreases blood alcohol concentrations by delaying gastric emptying. Eur J Clin Pharmacol 1997;53:241–246.
  • Kechagias S, Jönsson KA, Jones AW. Impact of gastric emptying on the pharmacokinetics of ethanol as influenced by cisapride. Br J Clin Pharmacol 1999;48:728–732.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.